JNIS editor Rob Tarr talks to Charles Kerber (University of California San Diego Medical Center) about Neucrylate, a new treatment for berry aneurysms.

Dr Kerber describes how his company developed the liquid embolic device, the results they’ve had using it, and future plans to get it into practice.

See also:
1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. II. Rabbit implant studies: technique and histology
1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. I. Theoretical basis and laboratory evaluation
1-Hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new treatment for berry aneurysm. III: Initial clinical results

Neucrylate - a new treatment for berry aneuryms [13:21m]:

 

Play Now

Play in Popup

Download

In this podcast, Robert Tarr, JNIS editor, talks to Marc Lazzaro, Medical College of Wisconsin, about his paper The impact of diabetes on the extent of pial collaterals in acute ischemic stroke patients - September’s Editor’s Choice.

See also:
Ischemic stroke - The impact of diabetes on the extent of pial collaterals in acute ischemic stroke patients

Diabetes and the extent of pial collaterals [10:36m]:

 

Play Now

Play in Popup

Download

In the monthly JNIS podcast, we will hear from some of the researchers who have published in the journal about their work.

In this inaugural podcast, Robert Tarr, JNIS editor, talks to Raymond Turner, Medical University of South Carolina, about his paper Novel Non-Occlusive Temporary Endoluminal Neck Protection Device to Assist in the Treatment of Aneurysms in a Canine Model - September’s Editor’s Choice.

See also:
New devices - Novel non-occlusive temporary endoluminal neck protection device to assist in the treatment of aneurysms in a canine model

Neck Protection Device to Assist in the Treatment of Aneurysms [12:06m]:

 

Play Now

Play in Popup

Download